
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Revascularization devices are tools or equipment used in medicine to open up clogged or damaged blood arteries and allow blood to flow again.
These gadgets are vital for the treatment of numerous cardiovascular disorders, especially those that affect the brain and heart.
Revascularization techniques aim to bypass or widen blood arteries that have been clogged or restricted, allowing sufficient blood flow to tissues and organs that are crucial to life. When blood flow is impeded as a result of vascular anomalies like blood clots or atherosclerosis (plaque build-up), this is frequently required.
Small mesh-like tubes known as stents are frequently created from metal or synthetic materials. They are employed to support open clogged or constricted blood arteries.
By preserving blood flow in the blood channels of the heart, coronary stents, for instance, are used to treat coronary artery disease.A flexible tube with an inflating balloon at the tip makes up a balloon catheter.
They are utilised in procedures such as percutaneous transluminal angioplasty (PTA) and balloon angioplasty. The clogged conduit widened and improved blood flow as a result of the balloon's inflation inside of it.
Devices known as neurovascular devices are created expressly to treat diseases that affect the brain's and central nervous system's blood vessels.
These include tools used to treat cerebral aneurysms, stroke, and other neurovascular conditions, such as flow diverters, embolisation coils, and stent retrievers.Revascularization tools are now necessary equipment for interventional cardiologists, radiologists, and neurosurgeons since they have considerably improved the management of cardiovascular disorders.
When applied properly, these gadgets can assist in reestablishing blood flow, easing symptoms, and enhancing patient outcomes.
The anatomy, health, and level of competence of each patient and the medical team executing the treatment all play a role in the decision of which exact equipment to use.
For accurate and current information on revascularization devices and their uses, it is always necessary to speak with a healthcare practitioner.
The global revascularization devices market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The Solitaire X Revascularization Device has been made available in the United States, and Medtronic plc has announced its first patient trials for the treatment of acute ischemic stroke.
The newest generation stent retriever, the MBOTRAP® III Revascularization Device, is made to engage a variety of clot types, boost procedural confidence, and offer more specialised alternatives to accomplish the First Pass Effect (FPE).
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |